Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Gain Therapeutics (GANX)

Annual Return

Over the past 3 years, GANX has had an average annual return of -24.68%, underperforming the benchmark SPY, which returned +19.63% annual.

Over the past 5 years, GANX has had an average annual return of -27.46%, underperforming the benchmark SPY, which returned +12.73% annual.

Since Mar 18, 2021, GANX has had an average annual return of -28.67%, underperforming the benchmark SPY, which returned +14.47% annual.

202620252024202320222021
-42.85%+49.04%-33.83%+4.29%-42.35%-51.52%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026-44.10%+44.99%-25.67%-2.54%+3.14%+4.14%-9.38%-42.85%
2025-1.40%-0%-10.36%+7.33%-13.66%+1.71%-18.86%+36.27%-11.09%+10.76%+78.57%-8.00%+49.04%
2024+18.52%+16.03%-16.04%-22.28%-12.96%-49.80%-15.66%+0.93%+63.31%+40.47%-25.58%+16.13%-33.83%
2023+26.19%+5.30%+15.89%+4.34%-8.35%-2.82%-11.38%-16.64%-0.88%-12.80%-25.18%+52.54%+4.29%
2022-26.34%-7.73%+10.83%-16.37%-12.87%+20.78%+10.58%-13.34%-5.49%+2.44%-8.99%+2.98%-42.35%
2021+33.21%-19.03%-12.34%-5.56%-20.00%-2.51%-4.55%-6.51%+4.02%-25.00%-51.52%

Drawdown analysis of Gain Therapeutics (GANX)

The maximum drawdown for the GANX was -94.07%, occurring on Aug 13, 2024. This drawdown has not yet recovered.

The current GANX drawdown is -88.35%.

Since Mar 18, 2021 GANX has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 1 time
DepthStartTo BottomBottomTo RecoverEndTotal
-94.07%Apr 5, 2021845Aug 13, 2024OngoingOngoingOngoing
-7.96%Mar 22, 20211Mar 23, 20213Mar 26, 20214